Email Print

Capsugel opens quality control lab at Greenwood plant

Staff Report
Published Nov. 29, 2012

Capsugel, a manufacturer of capsules commonly used to deliver drug doses, announced Wednesday that it has opened a new quality control laboratory at its plant in Greenwood.

The new 9,600-square-foot laboratory will serve the company’s network of manufacturing sites and research-and-development laboratories in Boston and, Strasbourg and Colmar, France.

The company, headquartered in Morristown, N.J., and Bornem, Belguim, invested more than $3 million to create the Greenwood facility.

“Our new quality control laboratory positions Capsugel for future growth in an increasingly complex regulatory marketplace,” said Guido Driesen, president and CEO of Capsugel. “Our thorough testing equates to faster time to market as our products are designed to comply with today’s strict regulations.”

The Greenwood lab is equipped to provide a wide range of analytical and microbial testing, as well as development of color formulations.

Capsugel makes hard gelatin, liquid-filled, and vegetarian capsules used by drug and nutritional manufacturers.

Capsugel was sold in April 2011 by pharmaceutical giant Pfizer to Kohlberg Kravis Roberts, a private equity firm, for $2.38 billion.

The Greenwood facility, originally built in 1967, reportedly has about 700 employees.

Capsugel recorded about $750 million in sales and makes more than 80 billion hard capsules a year.

Do you give this article a thumbs up? Thumbs_upYes